Adolescent Health Programs: Rashtriya Kishor Swasthya Karyakram (RKSK)

Introduction:
The Ministry of Health and Family Welfare launched the Rashtriya Kishor Swasthya Karyakram (RKSK) on January 7th, 2014. This program targets adolescents aged 10-19 years, focusing on nutrition, reproductive health, and substance abuse. RKSK emphasizes adolescent participation, equity, gender equality, and partnerships with other sectors.

Purpose:

RKSK aims to help adolescents in India make informed health decisions and access the necessary services and support. It also guides states and districts in preparing adolescent health components for NHM plans and budgets.

National Adolescent Health Strategy:

In collaboration with UNFPA, the Ministry developed a strategy that shifts from a clinic-based approach to a holistic model addressing the full spectrum of adolescent health and development.

Objectives

1. Improve Nutrition: Reduce malnutrition and iron-deficiency anemia among adolescents.
2. Enhance Sexual and Reproductive Health: Increase knowledge, reduce teenage pregnancies, and support adolescent parents.
3. Enhance Mental Health: Address mental health concerns among adolescents.
4. Prevent Injuries and Violence: Promote attitudes to prevent injuries, violence, and gender-based violence.
5. Prevent Substance Misuse: Raise awareness about the dangers of substance abuse.
6. Address Non-communicable Diseases: Encourage healthy behaviors to prevent diseases like hypertension and diabetes.

Target Groups:
The program focuses on adolescents aged 10-19, covering all genders, urban and rural areas, school-goers and dropouts, married and unmarried, and vulnerable groups.

Strategies:

1. Community-based Interventions:

• Peer Education (PE)
• Quarterly Adolescent Health Days (AHD)
• Weekly Iron and Folic Acid Supplementation (WIFS)
• Menstrual Hygiene Scheme (MHS)

1. Facility-based Interventions:

• Strengthening Adolescent Friendly Health Clinics (AFHC)

1. Convergence:

• Within Health and Family Welfare: FP, MH, RBSK, NACP, and others.
• With Other Departments/Schemes: WCD, HRD, Youth Affairs, and Sports programs.

(more…)

Read More

“A comprehensive overview of the key milestones of the Expanded Program on Immunization (EPI) and its impact on child health in India.”

Expanded Program on Immunization (EPI)

Introduction:

Smallpox Eradication: Showed the effectiveness of immunization in India.

• EPI Launch: The World Health Organization (WHO) started the “Expanded Program on Immunization” to protect children from six major diseases: diphtheria, pertussis (whooping cough), tetanus, poliomyelitis (polio), tuberculosis, and measles.
• Support: UNICEF has continuously supported this program.

Key Points:

• “Expanded” Meaning: Adding more vaccines and ensuring the program reaches all parts of the country, especially underserved areas.
• Alma-Ata Conference (1978): Highlighted immunization as vital to achieving health for everyone by 2000.

Milestones:

1. 1978: India began the Expanded Program on Immunization (EPI), mainly in urban areas.
2. 1983: Introduced Tetanus Toxoid (TT) immunization for pregnant women.
3. 1985: EPI was renamed the “Universal Immunization Program” (UIP) by UNICEF, aiming to reduce deaths and illnesses from six vaccine-preventable diseases.

• Indigenous Vaccine Production: Increased to meet the program’s needs.
• Cold Chain System: Set up to ensure vaccines stay effective.
• 1989-90: All districts in India were covered.

1. 1986: Technology mission on immunization started, monitored under the Prime Minister’s 20-point program.
2. 1992: Child Survival and Safe Motherhood (CSSM) program began, including UIP and safe motherhood initiatives.
3. 1995: Pulse Polio Immunization Program started, targeting children under five with additional polio doses during December and January.
4. 2005: National Rural Health Mission (NRHM) launched.
5. 2010-11: Hepatitis B vaccine added, given at 6, 10, and 14 weeks with DPT and OPV.
6. 2006: Japanese Encephalitis vaccine introduced in high-risk areas.
7. 2011: India introduced the pentavalent vaccine (DPT, Hepatitis B, Hib) in Kerala and Tamil Nadu.
8. 2013: Multi-dose vial policy and two doses of Japanese Encephalitis vaccine in endemic areas introduced.
9. 2014: Mission Indradhanush launched to vaccinate all children under five by 2020, with support from WHO, UNICEF, and Rotary International.
10. 2015: Inactivated Polio Vaccine (IPV) introduced in six states, expanded nationwide in 2016.
11. 2016: Rotavirus vaccine introduced in four states.

Components of Universal Child Immunization (UCI)

Overview:

• Two Main Components:

1. Immunization of Pregnant Women: Protects against tetanus with two doses of tetanus toxoid (TT) or a booster dose.
2. Immunization of Children: Targets diseases like diphtheria, pertussis (whooping cough), tetanus (DPT), polio (OPV), tuberculosis (BCG), and measles within the first year of life.

Goals:

• Pregnant Women: Achieve 100% coverage with two TT doses or a booster.
• Children: Reach 85% coverage with three doses of DPT, OPV, one dose of BCG, and one dose of measles by 1990.

Implementation:

• Initial Phase (1985): Began in 30 selected districts and 50 medical college catchment areas.
• Current Phase: Expanded to all districts and medical colleges, integrated with Maternal and Child Health (MCH) services, without additional staffing.

Program Implementation Plan (PIP) to Strengthen Routine Immunization

Key Strategies:

• Vaccine Delivery: Ensures smooth transportation of vaccines from Primary Health Centers (PHC) to sub-centers and outreach areas.
• Retired Manpower: Utilized in underserved slum areas to support immunization efforts.
• Mobility Support: Provided to district immunization officers for better supervision.
• Review Meetings: Held at the state level to monitor district progress.
• Community Mobilization: Assisted by ASHA workers, women’s self-help groups, and others to bring children to immunization clinics.
• Materials Support: Includes printing immunization cards, monitoring sheets, etc.
• Central Government Assistance:
• Auto-disposable syringes.
• Downsizing BCG ampoules from 20 to 10 doses.
• Cold chain maintenance to ensure vaccine potency.

Immunization Schedule 2020

Mandatory Vaccines:

• Administered to all children in India under the Universal Immunization Program (UIP) as per the latest guidelines by the Government of India and the Indian Academy of Pediatrics (IAP), following WHO recommendations.

Schedule Overview:

• Weeks (W), Months (M), and Years (Y): The schedule specifies when each vaccine should be given, tailored to the child’s age and health history.

National Immunization Schedule (NIS) – India 2020

For Infants and Children

Vaccine	When to Give	Dose
BCG	At birth or as early as possible till 1 year of age	0.1 ml (0.05 ml for infants under 1 month)
Hepatitis B (Birth dose)	At birth or as early as possible within 24 hours	0.5 ml
OPV (zero dose)	At birth or as early as possible within the first 15 days	2 drops
Hepatitis B (1st dose)	6 weeks	0.5 ml
DPT (1st dose)	6 weeks	0.5 ml
OPV (1st dose)	6 weeks	2 drops
Hib (1st dose)	6 weeks	0.5 ml
Rotavirus (1st dose)	6 weeks	2.5 ml (liquid) or 1.5 ml (lyophilized)
IPV (1st dose)	6 weeks	0.5 ml
Hepatitis B (2nd dose)	10 weeks	0.5 ml
DPT (2nd dose)	10 weeks	0.5 ml
OPV (2nd dose)	10 weeks	2 drops
Hib (2nd dose)	10 weeks	0.5 ml
Rotavirus (2nd dose)	10 weeks	2.5 ml (liquid) or 1.5 ml (lyophilized)
IPV (2nd dose)	10 weeks	0.5 ml
Hepatitis B (3rd dose)	14 weeks	0.5 ml
DPT (3rd dose)	14 weeks	0.5 ml
OPV (3rd dose)	14 weeks	2 drops
Hib (3rd dose)	14 weeks	0.5 ml
Rotavirus (3rd dose)	14 weeks	2.5 ml (liquid) or 1.5 ml (lyophilized)
Measles/MR (1st dose)	9 completed months-12 months	0.5 ml
JE-I (1st dose)	9 completed months-12 months	0.5 ml
Vitamin A (1st dose)	9 completed months-12 months	1 ml (100,000 IU)
DPT (1st booster)	16-24 months	0.5 ml
OPV (1st booster)	16-24 months	2 drops
IPV (booster dose)	16-24 months	0.5 ml
Hib (booster dose)	16-24 months	0.5 ml
Measles/MR (2nd dose)	16-24 months	0.5 ml
JE-II (2nd dose)	16-24 months	0.5 ml
Vitamin A (2nd dose)	16-24 months	2 ml (200,000 IU)
Vitamin A (3rd to 9th dose)	Every 6 months from 2 years to 5 years	2 ml (200,000 IU) each
DPT (2nd booster)	5-6 years	0.5 ml

For Pregnant Women

Vaccine	When to Give	Dose
TT-1	Early in pregnancy	0.5 ml
TT-2	4 weeks after TT-1	0.5 ml
TT Booster	If previously vaccinated within 3 years	0.5 ml

Note: This table is based on the immunization schedule as recommended by the Ministry of Health and Family Welfare, Government of India

Routine and Catch-Up Dose Schedule for Vaccines

Hepatitis B

• Routine Dose:
• Birth dose within 24 hours.
• 1st dose at 6 weeks, 2nd dose at 10 weeks, and 3rd dose at 14 weeks.
• Catch-Up Dose:
• If missed, start with a dose as soon as possible, followed by 2 more doses at 1-month intervals.

Oral Polio Vaccine (OPV)

• Routine Dose:
• Birth dose, followed by doses at 6, 10, and 14 weeks.
• Booster at 4-6 years.
• Catch-Up Dose:
• Can be given up to 5 years of age.

Inactivated Polio Vaccine (IPV)

• Routine Dose:
• 3 primary doses at 6, 10, and 14 weeks.
• Booster dose at 12-18 months.
• Catch-Up Dose:
• If missed, give at least one dose along with OPV. Complete the primary doses as soon as possible.

DTP (Diphtheria, Tetanus, Pertussis)

• Routine Dose:
• 3 primary doses at 6, 10, and 14 weeks.
• 1st booster at 16-24 months.
• 2nd booster at 4-6 years.
• Catch-Up Dose:
• Missed doses can be completed up to 7 years of age.

Hib (Haemophilus influenzae type b)

• Routine Dose:
• 3 doses at 6, 10, and 14 weeks.
• Booster at 12-18 months.
• Catch-Up Dose:
• For children aged 1-5 years, 1-2 doses can be given based on age and previous doses.

Pneumococcal Conjugate Vaccine (PCV)

• Routine Dose:
• 3 primary doses at 6, 10, and 14 weeks.
• Booster at 15 months.
• Catch-Up Dose:
• For children 12-23 months, 2 doses at 4-week intervals.
• For children 2-5 years, 1 dose.

Rotavirus

• Routine Dose:
• 3 doses at 6, 10, and 14 weeks.
• Catch-Up Dose:
• Missed doses can be given before 8 months of age.

Influenza

• Routine Dose:
• 2 doses at 6 months of age (4 weeks apart).
• Annual dose thereafter.
• Catch-Up Dose:
• 2 doses can be given at any time for children under 9 years.

MMR (Measles, Mumps, Rubella)

• Routine Dose:
• 1st dose at 9-12 months.
• 2nd dose at 15-18 months or 4-6 years.
• Catch-Up Dose:
• 2 doses at 4-week intervals for children and adolescents.

Typhoid (Vi PS Conjugate)

• Routine Dose:
• Primary dose at 9-12 months.
• Booster at 2 years.
• Catch-Up Dose:
• Can be given up to 18 years of age.

Hepatitis A

• Routine Dose:
• 1 dose at 12-23 months (live vaccine) or 2 doses (killed vaccine) with a 6-month interval.
• Catch-Up Dose:
• Can be given up to 18 years of age.

Chickenpox (Varicella)

• Routine Dose:
• 1st dose at 12-15 months.
• 2nd dose at 4-6 years.
• Catch-Up Dose:
• 2 doses at a 3-month interval for children aged 7-12 years; 4-week interval for those 13 years and older.

Tdap (Tetanus, Diphtheria, Pertussis)

• Routine Dose:
• 1 dose at 11-12 years.
• Catch-Up Dose:
• Can be given to children aged 7-10 years if not fully immunized.

HPV (Human Papillomavirus)

Can be given up to 25 years, maintaining minimum intervals.

Routine Dose:

2 doses for girls aged 9-14 years, with a 6-month interval.

3 doses for girls 15 years and older (0, 1-2, 6 months).

Catch-Up Dose:

Can be given up to 25 years, maintaining minimum intervals.

(more…)

Read More

“Discover the evolution of maternal and child health programs in India from 1951 to RCH Phase-II, and explore the vital roles played by community health nurses in enhancing rural healthcare.”

---

Maternal and Child Health Related Programs:

“The journey of maternal and child health programs in India began in 1951 with the Family Planning Program. Over the decades, these initiatives have evolved significantly, culminating in the Reproductive and Child Health (RCH) Program Phase-II, launched in 2005 to further reduce maternal and child mortality and improve healthcare in rural areas.”

1. 1951: Family Planning Program Initiated

• India started its first family planning program to reduce birth rates and control population growth.

2. 1966: Family Planning Department

• A separate department was created to focus on family planning efforts.

3. 1974-79: Integrating Family Planning with Maternal and Child Health

• During the 5th Five-Year Plan, efforts were made to reduce the birth rate by integrating family planning with maternal and child health services.
• The program faced setbacks due to rigid enforcement of laws during 1977-78.

4. 1977-78: Transition to Family Welfare Program

• After learning from past experiences, the program was renamed the “Family Welfare Program,” emphasizing voluntary participation and health education.

5. 1992: Child Survival and Safe Motherhood (CSSM) Program

• This program included various initiatives such as:
  • Universal Immunization Program (UIP)
  • Oral Rehydration Therapy (ORT)
  • Prophylaxis programs for anemia and vitamin A deficiency
  • Introduction of Acute Respiratory Infection (ARI) control, First Referral Units (FRUs), and disposable delivery kits.

Reproductive and Child Health (RCH) Programs

Definition

• Reproductive and Child Health (RCH): Ensures the ability to reproduce safely, manage fertility, and have a healthy pregnancy and childbirth, leading to maternal and infant survival and well-being.

Historical Development

• India introduced several programs under the RCH approach to improve maternal and child health:

Major Milestones:

• 1992: CSSM Program
• 1997: RCH Phase-I
• 2005: National Rural Health Mission (NRHM)
• 2013: RMNCH+A Strategy (Reproductive, Maternal, Newborn, Child, and Adolescent Health)
• 2014: India Newborn Action Plan

RCH Phase-I (1997)

• Integrated family planning, CSSM, prevention, and management of reproductive tract infections (RTIs), sexually transmitted diseases (STDs), and AIDS.
• Key Interventions:
• Client-oriented services for men and women.
• Upgraded health facilities to provide quality care.
• Establishment of First Referral Units (FRUs) for emergency obstetric and newborn care.

Essential Services:

• Obstetric Care: Early antenatal registration, safe delivery options, postnatal visits.
• Emergency Obstetric Care: Critical to reducing maternal and neonatal mortality.
• 24-hour Delivery Services: At Primary Health Centers (PHCs) and Community Health Centers (CHCs).
• Medical Termination of Pregnancy (MTP) Act: Reduced deaths from unsafe abortions.

Immunization & Newborn Care:

• Universal Immunization Program (UIP): Part of RCH, covering vaccines like polio, tetanus, and measles.
• Essential Newborn Care: Focus on preventing hypothermia, infections, and promoting exclusive breastfeeding.

Diarrheal Disease Control:

• Use of low osmolarity Oral Rehydration Solution (ORS) and zinc to reduce severity.

Prevention of Vitamin A Deficiency:

• Vitamin A Supplementation: Administered to children at specific intervals to prevent deficiency.

Anemia Prevention in Children:

• Iron and folic acid supplementation for children from 6 months to 10 years and beyond.

Reproductive and Child Health Program – Phase II

Overview

• Launched: April 1, 2005
• Objective: To reduce maternal and child mortality and morbidity, focusing on rural healthcare.

Major Strategies

1. Essential Obstetric Care

• Institutional Delivery: Promoting deliveries in medical institutions.
• Skilled Attendance: Ensuring skilled personnel conduct deliveries.
• Emergency Obstetric Care: Providing urgent care during childbirth.
• Operationalizing FRUs: Establishing First Referral Units for emergency care.
• 24/7 Delivery Services: Round-the-clock delivery services at PHCs and CHCs.
• Strengthening Referral Systems: Improving the process of referring patients to higher care facilities.

Critical Determinants for FRUs

• Surgical Interventions: Available 24/7.
• Newborn Care: Continuous care for newborns.
• Blood Storage Facility: Must be operational at all times.

Essential Obstetric Care

• Institutional Delivery Promotion:
• 50% of PHCs and all CHCs to become 24-hour delivery centers by 2010.
• Staffed with 3-4 nurses/ANMs for continuous services.
• Skilled Attendance:
• Training and guidelines for safe delivery and management of complications.
• ANMs and LHVs trained to handle emergencies.
• Emergency Obstetric Care:
• FRUs provide services like cesarean sections, newborn care, and safe abortions.
• Facilities must include a functioning operation theater, labor room, and newborn care area.

Strengthening Referral System

• Funding for Panchayats: Initially provided funds for obstetrical emergencies, but alternative support like self-help groups and NGOs is being considered.
• Recent Initiatives:
• Training of MBBS Doctors: Specialized training in obstetric emergencies and cesarean sections.
• Blood Storage Centers: Established in FRUs following government guidelines.

New Initiatives under RCH Phase-II

• Rashtriya Bal Swasthya Karyakram (RBSK): Health program for children.
• Rashtriya Kishore Swasthya Karyakram (RKSK): Adolescent health program.
• Weekly Iron Folic Acid Supplementation (WIFS): Program to prevent anemia in adolescents.

Role of Community Health Nurse in RCH Program

Antenatal Care

• Early Registration: Ensures antenatal mothers are identified and registered early.
• Supervision: Oversees regular checkups, nutrition, weight gain, and screening for high-risk pregnancies.
• Tetanus Toxoid & Supplementation: Ensures administration of tetanus injections and iron/folic acid supplements.
• Preparation for Delivery: Guides mothers for safe home or institutional delivery.

Postnatal Care

• Visits and Assessments: Monitors mother and baby post-delivery for any complications, breastfeeding, and nutrition.
• Contraceptive Advice: Provides temporary and permanent family planning advice.

Child Care

• Newborn Care: Monitors health, including management of diarrhea and respiratory infections.
• Immunization: Ensures children receive all vaccines under the universal immunization program.
• Growth and Nutrition: Assesses and monitors the growth and nutritional status of the child.

These initiatives and the roles of community health nurses are critical to improving maternal and child health outcomes in India, particularly in rural areas.

---

(more…)

Read More

“Learn about the National Vector-Borne Diseases Control Program, focusing on essential strategies like disease management, integrated vector management, and community health education to combat malaria, dengue, and other vector-borne diseases.”

---

National Vector-Borne Disease Control Program (NVBDCP)

“National Vector-Borne Diseases are a significant health concern in India, with the National Vector-Borne Disease Control Program (NVBDCP) at the forefront of prevention and control efforts.”

• Purpose: Central program for controlling diseases spread by vectors like mosquitoes and sand flies in India.
• Diseases Covered: Malaria, Dengue, Lymphatic Filariasis, Kala-azar, Japanese Encephalitis (JE), Chikungunya.
• Transmission: All these diseases are transmitted by mosquitoes except Kala-azar (by sand flies).

Key Strategies

1. Disease Management:

• Early detection and complete treatment.
• Preparedness for epidemics and rapid response.

1. Integrated Vector Management:

• Indoor residual spray.
• Use of insecticide-treated bed nets.
• Anti-larval measures like source reduction.

1. Supportive Interventions:

• Health education and behavior change communication.
• Capacity building and training.
• Intersectoral convergence (collaboration across sectors).

---

Malaria Control Program

• Vision: Reduce malaria burden and aim for elimination.
• Goal: Achieve an Annual Parasite Index (API) of <1 per 1000 population by 2017.
• Strategies:
• Screening all fever cases for malaria.
• Treating all positive cases promptly and effectively.

Preventive Measures

1. Against Larvae:

• Use larvicides in stagnant water (e.g., Temphos, Paris green).

1. Against Adult Mosquitoes:

• Spray residual insecticides like DDT.
• Use mosquito nets and repellents.

1. Community Protection:

• Promote protective clothing and use of mosquito mesh.
• Educate the community about prevention and management.

Health Education

• Essential for informing the community about the causes, spread, and prevention of vector-borne diseases.
• Use various educational approaches for effective communication.

This summary provides a clear overview of the key points related to National Vector-Borne Diseases and their control.

---

National Malaria Control Program Under NVBDCP.

• Main Goal: Control and prevent malaria through effective strategies and treatment.
• Diagnosis & Treatment:
• Check for malaria with blood smears (thin and thick).
• Start treatment while waiting for lab results (presumptive treatment).
• Follow the treatment plan based on the type of malaria detected.
• Ensure the first dose is given under observation.
• Role of Community Health Nurse:
• Monitor vital signs of all patients.
• Never ignore any case of fever.
• Educate patients and their families about malaria.
• Advise patients to drink plenty of water and monitor for vomiting after taking medicine.
• If the patient shows signs of severe illness (e.g., drowsiness), refer them to the hospital immediately.
• Follow-up: Regularly check on the patient and their family to ensure recovery and prevent further spread of malaria.

---

Lymphatic Filariasis Elimination Program: Simple Notes

• Disease Overview:
• Lymphatic filariasis, also known as elephantiasis, is a tropical disease affecting over 120 million people worldwide.
• It causes severe disfigurement and disability in about 40 million people.
• Program History:
• The National Filarial Control Program (NFCP) began in 1955.
• In 2003, it was included in the National Vector Borne Disease Control Program (NVBDCP).
• Training and research are conducted by the National Institute of Communicable Diseases, Delhi.
• Elimination Definition:
• The disease is considered eliminated when less than 1% of the population carries the microfilaria, and new-borns are free from the infection.
• Major Activities:
• Goal: The goal is to eliminate lymphatic filariasis by 2015, as per the National Health Policy 2002.
• Strategies:
  • Annual mass drug administration (MDA) with a single dose of antifilarial drugs like DEC and Albendazole for at least 5 years.
  • Home-based care for lymphedema and hydrocele surgeries.
  • Anti-larval and anti-mosquito measures in endemic areas.
  • Improved sanitation, including drainage facilities and preventing water stagnation.
  • Health education on environmental cleanliness and use of insect repellents.
• Exclusions from MDA:
• Pregnant women, children under 2 years, and seriously ill people are excluded from MDA.
• Ongoing Efforts:
• Microfilarial surveys and drug administration are regularly conducted to monitor progress.
• Public awareness campaigns encourage regular treatment and home care management.

---

Kala-Azar Control Program:

• Program Overview:
• The Kala-azar control program is a centrally sponsored initiative launched in 1990-91.
• Before the use of DDT, Kala-azar was highly endemic in India, causing significant economic harm due to high morbidity and mortality.
• Elimination Strategies:
• Enhanced Case Detection: Improved methods for finding and treating cases.
• Rapid Diagnostic Kits: Introduction of PK39 kits for quick diagnosis.
• Oral Drug “Miltefosine”: Used for treating Kala-azar.
• Vector Control: Fogging with pyrethroid instead of DDT to eliminate sandflies.
• Behavioral Impact Communication: Educating the community to encourage cooperation in eradication efforts.
• Capacity Building: Strengthening the skills of healthcare providers.
• Supervision & Monitoring: Regular checks and evaluations to ensure program effectiveness.
• Case Search for Kala-azar:
• Quarterly Searches: More frequent searches, called “Kala-azar fortnight surveys,” involving door-to-door visits.
• Incentives: ASHA workers receive ₹300 per identified case and ₹100 for community support during insecticide sprays. Patients receive ₹500 during hospitalization.
• Revised Eradication Strategy (2014):
• New Diagnostic Tools: Introduction of RDT developed by ICMR.
• New Treatment: Liposomal Amphotericin B (IV 10 mg-single dose) provided free by WHO.

---

Japanese Encephalitis (JE) Control Program:

• Disease Overview:
• JE is a severe disease causing up to 20,400 deaths annually worldwide.
• Survivors often suffer from long-term neurological issues such as paralysis or seizures.
• The disease is prevalent in rural and peri-urban areas of several Indian states.
• Vector Control Strategies:
• Alternate Wet and Dry Irrigation (AWDI): Helps control mosquito breeding by disrupting their lifecycle in paddy fields.
• Biological Control: Use of natural predators like Gambusia fish to control mosquito populations.
• Chemical Control: Application of deltamethrin, organophosphates, and carbamates to reduce mosquito numbers.
• Health Education:
• Community Involvement: Educate and engage communities in cleaning surroundings and eliminating mosquito breeding sites.
• Personal Protective Measures: Wearing full-sleeved clothing, using mosquito nets, and applying repellents.
• Management:
• No specific treatment is available; supportive care includes feeding, airway management, and seizure control.
• Long-term care and rehabilitation may be needed for survivors.
• Surveillance:
• Clinical Surveillance: Early diagnosis and management of JE patients at primary health centers.
• Vector Surveillance: Monitoring mosquito behavior in risk areas to adapt control measures accordingly.

---

Dengue Control:

Overview:

• Dengue is prevalent in tropical and subtropical regions worldwide.
• Severe dengue is a leading cause of death among children in some Asian and Latin American countries.
• A significant dengue outbreak occurred in Delhi in 1996.

Government Actions:

• 311 hospitals were identified for laboratory support in endemic areas.
• 14 Apex Referral Laboratories were linked with these hospitals for better case management.

Eight Key Elements for Dengue Prevention and Control:

1. Surveillance:

• Continuous monitoring in areas with Aedes aegypti and A. albopictus mosquitoes.
• Sentinel clinics report fever cases (above 38°C) to public health authorities for further blood tests and identification.

1. Case Management:

• Focus on laboratory diagnosis and effective clinical management of dengue cases.

1. Vector Management:

• Source Reduction: Eliminate breeding sites for mosquitoes.
• Chemical Control: Use of insecticides to control mosquito populations.
• Personal Protection: Encourage the use of mosquito repellents and nets.
• Legal Measures: Implement laws to enforce mosquito control efforts.

1. Outbreak Response:

• Epidemic Preparedness: Prepare for potential outbreaks with resources and planning.
• Media Management: Use media to inform the public during outbreaks.

1. Capacity Building:

• Training: Provide training for healthcare workers.
• Infrastructure Development: Improve facilities and resources.
• Operational Research: Conduct research to improve dengue control methods.

1. Behavioral Change Communication:

• Social Mobilization: Engage the community in dengue prevention efforts.
• Information, Education, and Communication (IEC): Spread awareness about dengue prevention.

1. Inter-sectoral Coordination:

• Work together with both health and non-health sectors to control dengue.

1. Monitoring and Supervision:

• Regular review, field visits, analysis of reports, and providing feedback for continuous improvement.

---

Chikungunya and Guinea Worm Disease Control:

Chikungunya Overview:

• The name “Chikungunya” comes from the Kimakonde language, meaning “to become contorted,” referring to the joint pain and stooped posture it causes.
• Chikungunya has spread to over 60 countries, especially in Asia.
• Prevention, control, and surveillance strategies are similar to those used for Dengue.

Role of Community Health Nurse in Chikungunya Control:

1. Environmental Control:

• Educate the community on reducing mosquito-breeding sites by eliminating water-filled containers, both natural and artificial.

1. Personal Protective Measures:

• Wear clothing that minimizes skin exposure to mosquito bites.
• Treat clothes with permethrin to repel mosquitoes if possible.
• Apply mosquito repellents containing DEET to exposed skin.
• Use insecticide-treated mosquito nets and mosquito coils to prevent indoor bites.
• Install insect screens on windows and doors to keep mosquitoes out.

---

Guinea Worm Disease (Eradication Program) Overview:

• Guinea worm disease is a disabling parasitic disease that was common in rural areas with step-wells.
• The last case in India was reported in 1996.
• The World Health Organization (WHO) declared India and other South East Asian countries free of Guinea worm disease.

Key Activities in Guinea Worm Eradication:

1. Health Education:

• Focus on educating rural women and children about preventing Guinea worm disease.

1. Rumor Registration and Investigation:

• Keep track of any rumors about Guinea worm cases and investigate them thoroughly.

1. Surveillance:

• Continue monitoring areas previously infected with Guinea worm.
• Maintain Guinea worm disease on the notified list of diseases.

1. Safe Water Supply:

• Ensure the proper functioning of hand pumps and other safe drinking water sources to prevent the spread of the disease.

(more…)

Read More

“Learn the essential steps for the vital signs procedure, including accurate blood pressure measurement, temperature assessment, and pulse measurement. Ensure patient safety and effective care.”

Vital Signs Procedure: Temperature, Pulse, and Respiration (TPR)

Table: TPR Procedure and Rationale

Sl. No.	Steps of Procedure	Rationale
1	Explain the procedure to the client.	To relieve anxiety and build an interpersonal relationship.
2	Collect all articles needed for the procedure.	Saves time and energy.
3	Wash hands thoroughly.	Minimizes the risk of cross-infection.
4	Provide privacy for the client (axillary/rectal).	Ensures client comfort and maintains dignity.
5	Prepare the thermometer:
5a	If in disinfectant, rinse in plain water.	Removes antiseptic solution to avoid tissue irritation.
5b	Wipe with a dry cotton swab, from bulb to stem.	Wiping from least contaminated to most contaminated area prevents infection.
5c	Shake down the thermometer below 96°F (36.5°C).	Ensures an accurate reading.
5d	Lubricate thermometer (rectal route).	Reduces friction and promotes comfort for the client.

Checking the Temperature:

Oral Method:

1. Place the thermometer in the right/left sublingual area.
2. Instruct the patient to close their mouth around the thermometer.
3. Hold the thermometer in place for 2-3 minutes.

Axillary Method:

1. Check the axilla for sweating; if present, dry it.
2. Place the bulb of the thermometer in the center of the axilla.
3. Position the arm tightly across the chest.
4. Hold the thermometer in place for 3-5 minutes.

Rectal Method:

1. Don gloves for protection.
2. Instruct the patient to breathe deeply.
3. Insert the lubricated thermometer gently:

• 3.54 cm in adults.
• 2.5 cm in children.
• 1.5 cm in infants.

1. Hold the thermometer in place for 1-2 minutes.
2. Do not force insertion to avoid injury.

This table and the procedure ensure proper technique and safety when measuring vital signs, which is crucial for accurate assessment and patient comfort.

Pulse Measurement Procedure

Steps for Assessing Pulse

Step No.	Steps of Procedure	Rationale
1	Select the appropriate peripheral site based on assessment data.	Ensures the most accessible and accurate pulse point is chosen.
2	Move the patient’s clothing to expose only the chosen site.	Maintains patient dignity while keeping the rest of the body warm.
3	Place the index, middle, and ring fingers over the artery.	Ensures maximum sensitivity to detect pulsations.
4	Lightly compress the artery to feel the pulsations.	Prevents excessive pressure that could occlude the pulse.
5	Feel the pulsation of the artery.	Allows for accurate counting of the pulse rate.
6	Ensure the warmest area in the mouth is used for temperature measurement.	Reflects true body temperature accurately.
7	Prevent air from entering the measurement site.	Ensures an accurate reading by minimizing external temperature influence.
8	Expose only the site for pulse assessment.	Keeps the patient warm and maintains privacy.
9	Encourage the patient to take a deep breath.	Relaxes the external sphincter and facilitates easy insertion of the thermometer (if applicable).
10	Ensure safety and accuracy of measurement.	Reduces the risk of injury or inaccurate readings.
11	To prevent cross-infection, use gloves as necessary.	Protects both the patient and the healthcare provider.

Respiration Measurement Procedure

Steps for Assessing Respiration

Step No.	Steps of Procedure	Rationale
1	Using a watch with a second hand, count the number of pulsations felt for 1 minute.	Ensures accuracy of measurement and assessment of pulse rate.
2	While your fingers are still in place for the pulse measurement, observe the patient’s respirations.	Allows for a seamless transition to respiratory assessment without drawing attention.
3	Note the rise and fall of the patient’s chest.	A complete cycle of an inspiration and expiration constitutes one respiration.
4	Using a watch with a second hand, count the number of respirations for 1 minute.	Provides a precise count for assessing the respiratory rate.
5	Remove the thermometer and wipe off secretions from the stem to bulb in a rotary manner using a cotton ball.	Ensures cleanliness and prevents cross-contamination.
6	Read the temperature by holding the thermometer at eye level.	Promotes accurate reading of the temperature.
7	Shake down the mercury level if necessary.	Resets the thermometer for accurate future readings.
8	Clean the thermometer using soap and water from stem to bulb.	Maintains hygiene and prevents infection.
9	Store the thermometer in a disinfectant solution.	Ensures the thermometer is sanitized and safe for future use.
10	Inform the client about their temperature as per requirement.	Keeps the client informed and involved in their health care.
11	Wash hands and replace articles after completing the procedures.	Ensures proper infection control and hygiene practices.
12	Record temperature, pulse, and respiration.	Documentation is essential for tracking patient health.
13	Report to the physician if needed.	Ensures timely medical intervention if abnormal readings are noted.

Blood Pressure Measurement Procedure

Table: Procedure for Blood Pressure Measurement

Step No.	Steps of Procedure	Rationale
1	Check physician’s order, nursing care plan, and progress notes.	Obtains any specific instruction or information needed for accurate assessment.
2	Explain the procedure and reassure the patient.	Obtains patient’s consent and cooperation, and relieves anxiety.
3	Ensure the patient has not smoked, ingested caffeine, or engaged in strenuous activity within 30 minutes prior to the procedure.	Smoking and caffeine can increase blood pressure.
4	Wash and dry hands.	Prevents cross-infection.
5	Assist the patient to either a sitting or lying down position, ensuring legs are not crossed.	Ensures comfort and obtains an accurate reading.
6	Collect and check equipment.	Ascertains evidence of malfunction to ensure accurate measurements.
7	Position the sphygmomanometer at approximately heart level, ensuring the mercury level is at zero.	Helps obtain an accurate reading.
8	Select a cuff of appropriate size.	Ensures that the compression bladder width is at least 20% wider than the circumference of the extremity used.
9	Expose the arm to ensure no constrictive clothing is present above cuff placement.	Ensures accurate reading by preventing obstruction of blood flow.
10	Apply the cuff approximately 2.5 cm above the point where the brachial artery can be palpated.	Ensures accurate placement of the cuff.
11	Wrap the cuff smoothly and firmly, ensuring the middle of the rubber bladder is directly over the artery.	Ensures accurate reading; wrapping too tightly may impede circulation, while too loosely may lead to falsely elevated pressure.
12	Secure the cuff by locking the end under the Velcro fastener.	Ensures the cuff remains in place during measurement.
13	Place the entire arm at the patient’s heart level and keep it well rested and supported.	Ensures comfort and accuracy of the reading.
14	Position yourself comfortably.	Allows for better focus and control during the procedure.
15	Connect the cuff tubing to the manometer and close the valve of the inflation bulb.	Prepares for inflation and measurement.
16	Palpate the radial pulse and inflate the cuff until the pulse is obliterated.	Ensures accurate determination of systolic pressure.
17	Inflate the cuff an additional 20-30 mm of mercury and then deflate slowly.	Prepares to accurately measure the systolic pressure.
18	Note the point at which the pulse reappears and release the valve.	Indicates the systolic pressure.
19	Palpate the brachial artery and place the diaphragm of the stethoscope lightly over it.	Ensures accurate detection of Korotkoff sounds.
20	Ensure that the ear pieces of the stethoscope are placed correctly.	Maximizes sound transmission for accurate reading.
21	Raise the mercury level 20-30 mm of mercury above the estimated systolic pressure.	Avoids missing the first sound heard during deflation.
22	Release the valve of the inflation bulb, allowing the mercury column to fall at 2-4 mm of mercury per second.	Ensures a controlled rate of deflation for accurate readings.
23	When the first sound is heard, note the mercury level; this denotes systolic pressure.	Confirms the systolic reading.
24	Continue to deflate the cuff until the sounds muffle; this indicates diastolic pressure.	Confirms the diastolic reading.
25	Deflate the cuff completely, disconnect the tubing, and remove the cuff from the patient’s arm.	Concludes the measurement process.
26	Repeat the procedure after one minute if there is any doubt about the reading.	Ensures accuracy of measurements if there were any uncertainties.
27	Ensure that the patient is comfortable.	Promotes patient satisfaction and well-being.
28	Remove equipment and clean the earpiece with a clean swab.	Prevents cross-infection and maintains hygiene.
29	Wash and dry hands.	Ensures proper infection control.
30	Document the reading in the appropriate observation chart or flow chart.	Essential for tracking and monitoring patient health.
31	Report any abnormal findings to the physician.	Ensures timely intervention and appropriate patient care.

(more…)

Read More